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Introduction
Idiopathic generalized epilepsies (IGEs) are a group of 
epilepsy disorders with presumed genetic etiology. Its 
characteristic electroencephalography (EEG) pattern 
consists of normal background activity intermingled with 
generalized frontal dominant > 3 Hz spike-wave (SW) 
or polyspike-wave (PSW) discharges.1 GGE accounts for 
about 15%–20% of all epilepsies.2
The potency to manipulate complicated, goal-oriented 
thoughts and behaviors is an executive function (EF) or 
cognitive regulation. To achieve this goal, a broad range of 
cognitive domains are required, including focus, inhibition 
control, concept formation, planning, working memory, 
problem solving, and mental flexibility.3 EF is a higher 
level of cognitive functioning, focusing largely on the 
function of the frontal lobe.3 Previous neuropsychological 
evaluations and novel neuroimaging techniques in 
patients with IGE demonstrated evidences of frontal lobe 
dysfunction.4,5 Neuropsychological assessment profile in 
adult patients with IGE have a wide variety of deficits of 
frontal lobe function.6,7
Frontal Assessment Battery (FAB) was designed to 
assess frontal lobe impairment in a diversity of patients as 
a rapid and convenient clinical test.8 FAB is divided into 
six subtests, each of which assesses the EF that is assumed 
to rely on the frontal cortex (conceptualization, mental 
flexibility, motor programming, interference, inhibitory 
control, and environmental autonomy).9
FAB has been commonly used in a number of various 
neurological disorders in recent years, including 
frontotemporal dementia,10 Huntington’s disease,11 
Parkinson’s disease,12 Alzheimer’s disease,13 temporal lobe 
epilepsy,14 and juvenile myoclonic epilepsy (JME).15 A 
brain imaging study demonstrated association between 
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Abstract
Background: Executive dysfunction is seen in idiopathic generalized epilepsy (IGE). The Frontal 
Assessment Battery (FAB) is a short neuropsychological instrument designed in clinical settings to 
evaluate frontal lobe activity. We aimed to assess the clinical use of FAB in patients with IGE for to 
detect executive impairment.
Method: In this study, 30 patients with IGE and 30 age- and sex-matched healthy controls were 
included. The presence and severity of executive dysfunction was investigated with FAB. Cognitive 
flexibility, decision making, working memory, and general intelligence level were examined 
using Wisconsin Card Sorting Task (WCST), Iowa Gambling Task (IGT), N-back, and Wechsler 
Adult Intelligence Scale, respectively. In patients with IGE, FAB results were related to their 
neuropsychological task performance.
Results: The FAB score in patients with IGE was significantly lower compared to healthy participants. 
In motor programming tasks, patients with IGE performed substantially worse. However, no 
correlation was found between FAB and neuropsychological task and clinical characteristics. 
Conclusion: Executive dysfunction was present in patients with IGE and FAB may be used in these 
patients as an effective tool for evaluating frontal lobe function.
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FAB results and perfusion in the medial and dorsolateral 
frontal cortex.16 Compared to healthy controls, patients 
with JME showed lower scores in conceptualization, 
mental flexibility, programming, sensitivity to 
interference, and total FAB score.15 However, association 
between FAB and formal EF measurements have not been 
investigated specially in subtypes of patients with IGE. We 
aimed to apply FAB with other EF tests in patients with 
IGE and compare it with healthy individuals.
Materials and Methods
Participants
This analytical cross-sectional study was performed on 30 
patients diagnosed with IGE, and 30 healthy individuals. 
According to the International League Against Epilepsy 
(ILAE) definitions, IGE syndromes are classified into 
four groups, based on clinical history and seizure 
types, as follows: childhood absences epilepsy (CAE), 
juvenile absences epilepsy (JAE), JME, and epilepsy with 
generalized tonic–clonic seizures alone (GTCS-alone).17 
Patients in the IGE group had at least one recorded EEG 
with typical normal background rhythm intermingled 
with frontally predominant generalized >3 Hz SW or/and 
PSW discharges. Age, sex, duration of epilepsy, types of 
seizures, frequency of attacks, and risk factors for epilepsy 
and the medication history were determined. Exclusion 
criteria were: (a) patients under the age of 18 or over 50 
years of age, (b) those with other medical, neurological 
(Parkinson’s disease, dementia, stroke, etc), and 
psychological conditions (schizophrenia, bipolar mood 
disorder, etc), or history of recent head trauma or those 
with intellectual disability. Healthy volunteers without a 
history of seizures were included in the control group.
Neuropsychological Tests
According to previous research, we selected an extensive 
battery of neuropsychiatric tests (table 2) that were stated 
to be useful in patients with IGE: Wisconsin Card Sorting 
Task (WCST, Cognitive flexibility), Iowa Gambling Task 
(IGT, decision making), and N-back (working memory). 
Based on a wide sample of healthy participants, all the 
chosen assessments had accurate scoring parameters, 
short administration time, and were standardized.
The FAB has previously been validated in Persian.18 Each 
test item is counted from 0 to 3; the overall score ranges 
from 0 to 18 and shows executive impairment and its 
severity. In this study, the six subsets of this method were 
evaluated as follows: (a) Similarities (conceptualization), 
(b) Lexical fluency (mental flexibility), (c) Motor series 
“Luria” test (programming), (d) Conflicting instructions 
(sensitivity to interference), (e) Go–No-Go (inhibitory 
control), (f) Pretension behavior (environmental 
autonomy)
Statistical Analysis
Statistical analyses were performed using SSPS software, 
version 22.0 (SPSS, Inc., Chicago, IL, USA). To evaluate 
normal data distributions, Kolmogorov–Smirnov test 
was used. Chi-square and independent t test were applied 
to analyze categorical and numerical data, respectively. 
Group differences (in IGE and healthy control (HC) 
s) for each neuropsychological tasks were compared 
using independent t test. To determine the strength and 
direction of the linear correlation between variables, 
Pearson correlation coefficient was calculated. Spearman 
rank coefficient was applied when non-normality data 
was present. P < 0.05 was estimated as significant.
Results
In this study, 30 patients with IGE and 30 controls were 
included. The clinical and demographic characteristics of 
the patients are shown in Table 1. In terms of age, sex, and 
level of education there were no significant differences 
between the two groups.
In contrast to healthy controls, the overall FAB rates 
were noticeably lower in patients with IGE (P < 0.04). As 
shown in Table 2, significantly lower scores in the motor 
programming subtest were obtained from patients with 
IGE (P < 0.01). 
Student’s t test showed significant differences in the 
WCST test between patients with IGE and healthy 
controls. Patients with IGE had more preservative errors 
in WCST (P = 0.04). The two studied groups did not differ 
significantly in IQ, N-Back, and IGT (P > 0.05). The mean 
scores for every test are shown in Table 2. No correlation 
was observed between FAB and the clinical characteristics 
Table 1. Clinical Characteristics of Participants in the Study
Variables IGE (30) HC (30) P Value
Age 27.63±6 31.10±1 0.06
Sex (male/female) 10/20 14/16 0.292
Level of education
0.684
Primary 10 (33.3) 7 (23.3)
High School 10 (33.3) 12 (40)
Academic 10(33.3) 11 (36.7)
Disease Duration (y) 11.13±9.39
Frequency of Seizure (per month) 2.86±1.25
Diagnosis of Epilepsy 
JAE 7 (23.3)
JME 11 (36.7)




Abbreviation: IGE, idiopathic generalized epilepsy; AFD, Anti-epileptic drug; 
JAE, juvenile absences epilepsy; JME, juvenile myoclonic epilepsy; HC, 
healthy control
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of patients with IGE. Moreover, the neuropsychological 
tasks were not affected by the subtype of IGE (including 
JAE, JME and GTCS alone) or patients’ anti-seizure 
medications. 
Discussion
 The findings of this study are compatible with previous 
reports indicating impaired frontal lobe function in 
patients with IGE.15,19 The major findings of this study are 
as follows: (1) compared with healthy controls, patients 
with IGE showed lower total FAB score and lower score in 
motor programming; (2) disease duration and frequency 
of seizure had no effect on FAB scores in patients with IGE 
and EF tasks; (3) the number of AEDs (polytherapy versus 
monotherapy) and subtypes of IGE had no significant 
effect on FAB scores and EF tasks; and (4) Compared with 
healthy participants, the number of preservative errors in 
WCST in patients with IGE were lower. It suggests that 
this battery has good validity as a discriminant. 
Most previous studies evaluated EF by the Stroop 
test, the verbal fluency test, the digit span tests, the 
WCST, and the N-back, which are the gold standard for 
IGE executive skills assessment.20-23 However, more recent 
studies showed that the mentioned tests are not specific 
for frontal lobe functions.24 While frontal and prefrontal 
cortical areas play important roles in the success of the 
task, other brain areas are also largely involved, including 
the inferior parietal lobe, temporoparietal junction, and 
visual processing areas.24-26
The most commonly recorded impaired IGE skills are 
deficient working memory, impaired verbal fluency tasks, 
and language deficits, which are particularly, though not 
mainly, important for optimal frontal lobe activity.19,20,27 
However, previous studies have also identified problems 
in inhibitory control, and other main domains of EF.4,28
Typically, IGE is correlated with general intelligence, 
although several patients show different cognitive 
deficiencies in the frontal lobe.29,30 A meta-analysis 
found that except for visual-spatial skills, patients with 
IGE displayed substantially lower scores in all cognitive 
domains.19 The higher seizure frequency was associated 
with lower test scores.31
Interictal epileptiform discharges (IEDs) have been 
proposed to lead to frontal lobe dysfunction in patients 
with IGE. In a study by Jiang et al, as compared to patients 
without IEDs, IGE patients with IEDs conducted poorly 
on EF tests. Moreover, patients with IGE without IEDs 
performed worse than healthy controls.32 
There may be many reasons for these variations in 
outcomes. The complexity of the EFs could be one reason 
and the fact that not all the domains be necessary involved. 
In addition, because of the genotype and phenotype 
heterogeneity of the patients, the performance of all of 
them may not be uniform. Even some patients showed 
little or no significant deficits in the EFs.29,33
Many studies have found that EFs are involved in 
patients with JME29,34,35 and only a few studied patients 
with other forms of IGE syndrome.4,36,37 As a result, it 
seems important to provide more data on the EFs in IGE 
syndromes other than JME. In our study, the EFs have 
Table 2. The Mean ± SD of Neuropsychological Task 
Variables IGE HC P Value
Intelligent quotient 89.13±11.67 88.26±8.1 0.112
WCST
Categories achieved 3.33±2.1 3.89±1.79 0.279
Preservative errors 6.86±4.76 4.62±3.66  0.048*
N-Back
Reaction times 635.76±101.87 611.62±138.56 0.448
Correct response 89.03±26.06 94.51±29.90 0.455
IGT
Gain 9578.33±532.03 9400.0±528.47 0.254
Loss 7903.33±1297.07 7782.75±956.83 0.687
Total FAB score 15.86±1.62 16.73±0.9 0.04*
Conceptualization 2.86±0.3 2.90±0.3 0.694
Mental flexibility 2.23±0.6 2.43±0.6 0.24
Motor programming 2.66±0.4 2.93±0.2 0.01*
Sensitivity interference 2.50±0.5 2.66±0.4 0.197
Inhibitory control 2.56±0.5 2.80±0.4 0.05
Environmental autonomy 2.86±0.3 2.90±0.3 0.694
Abbreviations: IGE, idiopathic generalized epilepsy; WCST, Wisconsin Card Sorting Task; IGT, Iowa Gambling Task; FAB, Frontal Assessment Battery; HC, healthy 
control
* Significant <0.05.
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been assessed in the subgroups of patients with IGE, and 
no variations between the groups have been observed in 
any of the tasks.
Although the dosage and number of AEDs raised the 
risk of cognitive dysfunction,38 polytherapy in this study 
was not related to a more impaired EF. The main side 
effects of AEDs were memory deficiency and executive 
dysfunction. Older anticonvulsants tend to compromise 
cognition more than newer agents.39
Neuropsychological and functional imaging tests have 
demonstrated cognitive dysfunction in the frontal lobe. 
Microstructural abnormalities have been defined on the 
supplementary motor area as a key hub in a thalamo-
frontal cortical network.40,41 At a higher cognitive 
load, frontal lobe dysfunction tends to become more 
noticeable, which may account for the variability between 
the “normal “output results in patients with IGE on tasks 
that are not sufficiently difficult.
Conclusion
Although, IGE harbors a benign course, the probability of 
executive dysfunction was reported in these patients. In 
our study, impaired motor programing and preservative 
error were found in patients with IGE compared to the 
controls. The executive dysfunction in patients with 
IGE was not correlated with the epilepsy duration, 
types and dosage of anti-seizure medications, or IGE 
subtypes. Epilepsy is a disorder that affects widespread 
brain network rather than a discrete brain region. We 
proposed that FAB is a clinically applicable instrument for 
monitoring EF in patients with IGE. In the period of the 
disease, early neuropsychological evaluation may provide 
appropriate intervention where necessary. 
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